Form 8-K Edwards Lifesciences For: Jul 23

Go back to Form 8-K Edwards Lifesciences For: Jul 23

Edwards Lifesciences (EW) PT Raised to $217 at RBC Capital

July 24, 2019 6:47 AM EDT

RBC Capital analyst Brandon Henry raised the price target on Edwards Lifesciences (NYSE: EW) to $217.00 (from $186.00) while maintaining an Outperform rating.

Big TAVR Beat; TAVR Market Accelerated In 2Q19... More

Edwards Lifesciences (EW) PT Raised to $250 at Cowen

July 24, 2019 6:42 AM EDT

Cowen analyst Joshua Jennings raised the price target on Edwards Lifesciences (NYSE: EW) to $250.00 (from $210.00) while maintaining a Outperform rating.

The analyst commented, "EW printed a significant 2Q TAVR beat that will reinvigorate investor sentiment ahead of a string of anticipated back-half... More